Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
所公开的是作为 cGAS 拮抗剂的新型式 I 化合物、该化合物的制备方法、包含该化合物的药物组合物及其在医学治疗中的用途。
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science
作者:Sven Thamm、Marina K. Willwacher、Gary E. Aspnes、Tom Bretschneider、Nicholas F. Brown、Silke Buschbom-Helmke、Thomas Fox、Emanuele M. Gargano、Daniel Grabowski、Christoph Hoenke、Damian Matera、Katja Mueck、Stefan Peters、Sophia Reindl、Doris Riether、Matthias Schmid、Christofer S. Tautermann、Aaron M. Teitelbaum、Cornelius Trünkle、Thomas Veser、Martin Winter、Lars Wortmann
DOI:10.1021/acs.jmedchem.2c01884
日期:2023.2.23
[EN] cGAS ANTAGONIST COMPOUNDS<br/>[FR] COMPOSÉS ANTAGONISTES DU CGAS
申请人:IMMUNE SENSOR LLC
公开号:WO2017176812A1
公开(公告)日:2017-10-12
Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.